Top U.S. Honor Roll Hospital Expands Use of INSPIRA™ ART100 System to Lung Transplant Procedures

Core Insights - Inspira Technologies has expanded the clinical use of its INSPIRA™ ART100 system to lung transplantation procedures at a top U.S. hospital, indicating strong validation of the system's performance and clinical value [1][2] - The expansion reflects growing confidence from leading hospitals in Inspira's technology and highlights the ART100's potential as a reliable platform for advanced respiratory support [2][3] - The company has recently secured multi-million dollar binding government orders for ART100 systems, showcasing its increasing global footprint and commercial momentum [3] Company Overview - Inspira Technologies is a commercial-stage medical device company specializing in advanced respiratory support and real-time blood monitoring solutions [4] - The INSPIRA™ ART100 system is FDA-cleared for cardiopulmonary bypass in the U.S. and ECMO procedures outside the U.S., with plans for a next-generation system, the INSPIRA ART500, designed for awake patients [4] - The company is advancing its proprietary blood sensor platform, HYLA™, and is strategically streamlining operations to align with long-term industry trends such as consolidation and potential strategic partnerships [4]